TOP STORIES

• BUSINESS Moderna Files BA.4/5-Tailored COVID-19 Vaccine in Japan
  October 5, 2022

• REGULATORY Japan Panel OKs Inclusion of Silgard 9 into National Immunization Program
  October 5, 2022

• BUSINESS Novartis Homes in on 5 Therapy Areas and 4 Markets, Eyes Top 3 Multinational Rank in Japan: CEO
  October 4, 2022

• BUSINESS Celltrion Aims to Market 11 Biosimilars in Japan, Infliximab “Biobetter” in the List
  October 3, 2022

• REGULATORY Japan Ends Supply of AstraZeneca’s COVID Jab, 13.5 Million Doses Discarded
  October 3, 2022

• REGULATORY Wholesalers Question Inflexibility in Official Pricing, Sees Limit to Addressing Rising Costs
  September 30, 2022

• BUSINESS Ferring Japan CEO Confident of Growth in Fertility Drugs Spurred by Rising Demand on Health Coverage
  September 30, 2022

• BUSINESS Lecanemab Hits PIII Mark with 27% Cut in Clinical Decline, Eisai Set for Submissions by March-End
  September 29, 2022

• ORGANIZATION Policy Veterans’ Group Proposes Simple Drug Price Maintenance Scheme for Patented Meds
  September 28, 2022

• REGULATORY Japan Approves Mounjaro, Tezspire, Fintepla, Label Expansions for Rinvoq/Skyrizi, Keytruda, and More
  September 27, 2022

• BUSINESS Ivermectin Misses Goal in PIII COVID-19 Trial: Kowa
  September 27, 2022

• REGULATORY Revamped Expert Panel Holds Industry Hearing, Discussions Center on Drug Price Gap
  September 26, 2022

• BUSINESS Janssen Aims to Rank Among Top 3 Drug Makers in Japan by 2024: Local Chief
  September 22, 2022

• REGULATORY 2 Years after Full Rollout, Sakigake System Shows Tepid Uptake as Industry Sees Poor Incentives
  September 21, 2022

• REGULATORY MHLW Retools New Expert Panel, Industry Hearing Set for Sept. 22
  September 21, 2022

• BUSINESS Boehringer Ingelheim Revamping Biz Sites in Japan to Spur Communications among Drug Reps
  September 20, 2022

• BUSINESS Insmed CEO Sees Japan as Cornerstone of APAC Strategy, Doubling of Staff in Next 2 Years
  September 16, 2022

• BUSINESS Moderna to Have One of Industry’s Biggest Pipelines in 5 Years, Oncology Might Make Up 30% of Sales: CEO
  September 15, 2022

• BUSINESS Alnylam Japan Paints Two-Digit Annual Growth Outlook on ATTR Meds and Pipeline Drugs
  September 14, 2022

• BUSINESS Pfizer Seeks Japan Nod for BA.4/5-Adapted COVID-19 Vaccine
  September 13, 2022

ページ

• « 先頭
• ‹ Prev
• …
• 71
• 72
• 73
• 74
• 75
• 76
• 77
• 78
• 79
• …
• Next ›
• 最終 »